New funding opportunity for longevity clinical trials from National Institute on Aging emphasises preventing aging and age-related disease.
The NIA,...
New economic model estimates that targeting aging has larger economic gains than eradicating individual diseases: time for a policy pivot?
Although life expectancy has increased...
Open Life data project secures funding to help UK develop pandemic resilience and promote healthy life extension.
The All Party-Parliamentary Group (APPG) for Longevity has...
Open Life data project secures funding to help UK develop pandemic resilience and promote healthy life extension.
The All Party-Parliamentary Group (APPG) for Longevity has...
UK business confidence is at six-year high as biotech innovation and vaccine success dispel lockdown gloom.
Data from IHS Markit demonstrates that British business confidence...
Lancet commentary calls for immediate large-scale clinical trials of rapamycin and rapalogs, with geroprotective consequences.
In March last year, as the global coronavirus pandemic took...
Longevity, biotech, investment, sustainability and ethics: Jim Mellon's new book, MOO'S LAW, addresses the opportunities and challenges of our need for protein.
Getting time with...
New funds, switching focus to longevity, Silicon Valley blue-bloods and preparing for IPO.
Over the past year, we’ve had the pleasure of speaking with some...
2020's journey to extending healthy human longevity.
The journey to Longevity has many stages, whether it's a clinical pipeline, gaining regulatory approval for a drug,...
Looking for anti-aging solutions in some unusual places.
2020 has seen Longevity.Technology covering a variety of news in the Longevity sector, from discoveries in the...
Speaking to the innovators behind some of Longevity’s most exciting companies.
Continuing our look back at some of the highlights of 2020, we thought we’d...
Dr Lynne Cox explains the importance of geroprotectors – especially during COVID-19.
This month The Lancet launches its own journal on Longevity, publishing clinically-focused Longevity and...
New economic model estimates that targeting aging has larger economic gains than eradicating individual diseases: time for a policy pivot?
Although life expectancy has increased...
Professor Mikhail Blagosklonny takes a look at therapeutic research done within the longevity field and concludes that there must be a re-focusing on lifespan...
Longevity, biotech, investment, sustainability and ethics: Jim Mellon's new book, MOO'S LAW, addresses the opportunities and challenges of our need for protein.
Getting time with...
NAD+ metabolism in aging & three strategies to rejuvenate.
Welcome to The Sheekey Science Show!
Longevity.Technology is delighted to partner with YouTube sensation Eleanor Sheekey (interviewed...
Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement.
Far from just supplementing their diet to ensure an adequate...
Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing.
New York based health and wellness brand...
Company reveals primary indicator for BGE-117 clinical trial is unexplained anaemia of aging.
Hot on the heels of its monster $90 million Series C funding...
